le 135 Search Results


le135  (Tocris)
99
Tocris le135
Le135, supplied by Tocris, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/le135/product/Tocris
Average 99 stars, based on 1 article reviews
le135 - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
rarb antagonist le135  (Tocris)
92
Tocris rarb antagonist le135
Rarb Antagonist Le135, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rarb antagonist le135/product/Tocris
Average 92 stars, based on 1 article reviews
rarb antagonist le135 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
le135  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology le135
Figure 3. Cellular responses to ATRA in normal and p14ARF-depleted melanocytes. A, BrdUrd incorporation in primary human melanocytes grown for 48 hours in the presence or absence of ATRA (10 mmol/L) and in the presence or absence of <t>LE135</t> (1 mmol/L). B, FACS analysis showing representative cell-cycle profiles of normal human melanocytes cultured for 10 days in the presence or absence of ATRA (10 mmol/L). C, ATRA-induced senescence in two cultures of normal human melanocytes (WT-1 and -2) and two independent pools of melanocytes expressing shRNAs against CDKN2A sequences (HEM-1 and -2). Cells were treated with ATRA (10 mmol/L) for 2 weeks, and the number of senescent cells was determined by SA-b-Gal positivity. Columns represent percentage of SA-b-Gal–positive cells. D, the same data as in (C), but with the increase in senescence in normal melanocytes set at 100%. Statistical analysis was conducted using a paired t test. , P < 0.05; ns, nonsignificant.
Le135, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/le135/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
le135 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
beaumont (le mirage iv, 135)  (Dassault Systemes)
90
Dassault Systemes beaumont (le mirage iv, 135)
Figure 3. Cellular responses to ATRA in normal and p14ARF-depleted melanocytes. A, BrdUrd incorporation in primary human melanocytes grown for 48 hours in the presence or absence of ATRA (10 mmol/L) and in the presence or absence of <t>LE135</t> (1 mmol/L). B, FACS analysis showing representative cell-cycle profiles of normal human melanocytes cultured for 10 days in the presence or absence of ATRA (10 mmol/L). C, ATRA-induced senescence in two cultures of normal human melanocytes (WT-1 and -2) and two independent pools of melanocytes expressing shRNAs against CDKN2A sequences (HEM-1 and -2). Cells were treated with ATRA (10 mmol/L) for 2 weeks, and the number of senescent cells was determined by SA-b-Gal positivity. Columns represent percentage of SA-b-Gal–positive cells. D, the same data as in (C), but with the increase in senescence in normal melanocytes set at 100%. Statistical analysis was conducted using a paired t test. , P < 0.05; ns, nonsignificant.
Beaumont (Le Mirage Iv, 135), supplied by Dassault Systemes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/beaumont (le mirage iv, 135)/product/Dassault Systemes
Average 90 stars, based on 1 article reviews
beaumont (le mirage iv, 135) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
le 135  (Axon Medchem LLC)
90
Axon Medchem LLC le 135
Figure 3. Cellular responses to ATRA in normal and p14ARF-depleted melanocytes. A, BrdUrd incorporation in primary human melanocytes grown for 48 hours in the presence or absence of ATRA (10 mmol/L) and in the presence or absence of <t>LE135</t> (1 mmol/L). B, FACS analysis showing representative cell-cycle profiles of normal human melanocytes cultured for 10 days in the presence or absence of ATRA (10 mmol/L). C, ATRA-induced senescence in two cultures of normal human melanocytes (WT-1 and -2) and two independent pools of melanocytes expressing shRNAs against CDKN2A sequences (HEM-1 and -2). Cells were treated with ATRA (10 mmol/L) for 2 weeks, and the number of senescent cells was determined by SA-b-Gal positivity. Columns represent percentage of SA-b-Gal–positive cells. D, the same data as in (C), but with the increase in senescence in normal melanocytes set at 100%. Statistical analysis was conducted using a paired t test. , P < 0.05; ns, nonsignificant.
Le 135, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/le 135/product/Axon Medchem LLC
Average 90 stars, based on 1 article reviews
le 135 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3. Cellular responses to ATRA in normal and p14ARF-depleted melanocytes. A, BrdUrd incorporation in primary human melanocytes grown for 48 hours in the presence or absence of ATRA (10 mmol/L) and in the presence or absence of LE135 (1 mmol/L). B, FACS analysis showing representative cell-cycle profiles of normal human melanocytes cultured for 10 days in the presence or absence of ATRA (10 mmol/L). C, ATRA-induced senescence in two cultures of normal human melanocytes (WT-1 and -2) and two independent pools of melanocytes expressing shRNAs against CDKN2A sequences (HEM-1 and -2). Cells were treated with ATRA (10 mmol/L) for 2 weeks, and the number of senescent cells was determined by SA-b-Gal positivity. Columns represent percentage of SA-b-Gal–positive cells. D, the same data as in (C), but with the increase in senescence in normal melanocytes set at 100%. Statistical analysis was conducted using a paired t test. , P < 0.05; ns, nonsignificant.

Journal: Molecular Cancer Research

Article Title: Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14ARF and RARβ Signaling

doi: 10.1158/1541-7786.mcr-13-0006

Figure Lengend Snippet: Figure 3. Cellular responses to ATRA in normal and p14ARF-depleted melanocytes. A, BrdUrd incorporation in primary human melanocytes grown for 48 hours in the presence or absence of ATRA (10 mmol/L) and in the presence or absence of LE135 (1 mmol/L). B, FACS analysis showing representative cell-cycle profiles of normal human melanocytes cultured for 10 days in the presence or absence of ATRA (10 mmol/L). C, ATRA-induced senescence in two cultures of normal human melanocytes (WT-1 and -2) and two independent pools of melanocytes expressing shRNAs against CDKN2A sequences (HEM-1 and -2). Cells were treated with ATRA (10 mmol/L) for 2 weeks, and the number of senescent cells was determined by SA-b-Gal positivity. Columns represent percentage of SA-b-Gal–positive cells. D, the same data as in (C), but with the increase in senescence in normal melanocytes set at 100%. Statistical analysis was conducted using a paired t test. , P < 0.05; ns, nonsignificant.

Article Snippet: LE135 was purchased from Santa Cruz Biotechnology.

Techniques: Cell Culture, Expressing